Literature DB >> 1670005

A review of angiotensin converting enzyme in health and disease.

R K Allen1.   

Abstract

ACE, a carboxypeptidase that hydrolyses angiotensin-1 to angiotensin-2, is widely found in human tissues including vascular endothelium. It is also produced by epithelioid cells of sarcoid granulomata which elevate serum ACE, a useful test of active sarcoidosis, despite its less than optimal sensitivity and specificity. It is not known why ACE production is increased in only certain granulomatous disorders. The explanation may assist our understanding of the pathogenesis of sarcoidosis.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1670005

Source DB:  PubMed          Journal:  Sarcoidosis        ISSN: 0393-1447


  9 in total

1.  Chitotriosidase as a marker of disease activity in sarcoidosis.

Authors:  Jürgen Brunner; Sabine Scholl-Bürgi; Martina Prelog; Lothar-Bernd Zimmerhackl
Journal:  Rheumatol Int       Date:  2007-01-25       Impact factor: 2.631

2.  ACE gene variants and sarcoidosis in a Finnish population.

Authors:  Elisa Lahtela; Annika Wennerström; Anne Pietinalho; Martin Petrek; Vitezslav Kolek; Marja-Liisa Lokki; Olof Selroos
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2017-04-28       Impact factor: 0.670

3.  Successful steroid-sparing treatment of renal limited sarcoidosis with mycophenolate mofetil.

Authors:  Asha Moudgil; Ronald M Przygodzki; Kanwal K Kher
Journal:  Pediatr Nephrol       Date:  2005-12-17       Impact factor: 3.714

4.  Intramedullary sarcoidosis presenting with delayed spinal cord swelling after cervical laminoplasty for compressive cervical myelopathy.

Authors:  Du Ho Kwon; Sun-Ho Lee; Eun-Sang Kim; Whan Eoh
Journal:  J Korean Neurosurg Soc       Date:  2014-11-30

5.  Serum and tissue angiotensin converting enzyme in patients with lichen planus.

Authors:  Faruk Alendar; Jasminko Huskić; Nermina Babić; Nedzad Mulabegović
Journal:  Bosn J Basic Med Sci       Date:  2005-08       Impact factor: 3.363

Review 6.  Cardiac sarcoidosis: diagnostic, prognostic, and therapeutic considerations.

Authors:  M Sekiguchi; Y Yazaki; M Isobe; M Hiroe
Journal:  Cardiovasc Drugs Ther       Date:  1996-11       Impact factor: 3.727

Review 7.  Obstructive sarcoidosis.

Authors:  Petey Laohaburanakit; Andrew Chan
Journal:  Clin Rev Allergy Immunol       Date:  2003-10       Impact factor: 8.667

8.  Chitotriosidase as a marker of disease activity in sarcoidosis.

Authors:  Jürgen Brunner; Sabine Scholl-Bürgi; Lothar-Bernd Zimmerhackl
Journal:  Rheumatol Int       Date:  2007-05-30       Impact factor: 2.631

9.  Targeted acetylcholinesterase-responsive drug carriers with long duration of drug action and reduced hepatotoxicity.

Authors:  Yulong Lin; Yalin Wang; Jie Lv; Nannan Wang; Jing Wang; Meng Li
Journal:  Int J Nanomedicine       Date:  2019-07-26
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.